Using Components of the Circadian Clock to Regulate Stem Cell Fate Decisions
利用生物钟的组成部分来调节干细胞的命运决定
基本信息
- 批准号:7942482
- 负责人:
- 金额:$ 239.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-30 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdipocytesBiologyCellsCircadian RhythmsClinicCommitDevelopmentDiabetes MellitusDiseaseDrug DesignEventGlucocorticoidsHormonesHourHydrocortisoneKnowledgeMolecularMyopathyNuclear Hormone ReceptorsOsteoporosisPathway interactionsPatientsPharmaceutical PreparationsPlayRegenerative MedicineRegulationRoleStem cellsStreamTestingTranslationsanalogcircadian pacemakerimprovedin vivoinnovationnovelnovel therapeuticsprecursor cellpreventstem cell biologystem cell differentiationstem cell fatetool
项目摘要
DESCRIPTION (Provided by the applicant)
Abstract: Tantalizing advances in stem cell biology have led to the promise of incredible new therapeutic options for an array of illnesses. Yet, the reality is that continued obstacles have thus far delayed the translation of most these potential advances in regenerative medicine into the clinic where they can be used for patients. This is in part because of missing tools that control how and when stem cells commit to a lineage (stem cell fate) and differentiate. Glucocorticoids such as cortisol, the natural hormone, or a multitude of synthetic cortisol analogues used as drugs, are heavily relied upon in stem cell biology because of their potent ability to induce cell fate decisions and differentiation of precursor cells. For example, glucocorticoids play a critical role in the induction of adipocyte cell fate and differentiation both in vivo and ex vivo. In fact, glucocorticoids have been indispensable for the progress made in understanding down-stream events of stem cell differentiation. Yet, the mechanisms by which glucocorticoids initiate cell fate decisions is mostly unexplored. Here I propose a novel paradigm where the circadian clock, controlling 24-hour body rhythms, is embedded in the glucocorticoid pathway and is essential for the regulation of stem cell fate. To test my hypothesis, I will develop innovative, interdisciplinary tools to reveal the molecular connections between stem cells, nuclear hormone receptors and circadian rhythm biology. The new knowledge to be gained from these studies will likely allow the design of drugs to direct selective precursor cells down a desirable and healthful lineage of differentiation and away from a disease- oriented path. The potential significance is substantial for both understanding new aspects of stem cell biology and for the development of improved drugs to prevent and/or treat common debilitating diseases such as osteoporosis, degenerative muscle diseases and diabetes.
Public Health Relevance: The emergence of the field of stem cell biology has raised the real potential for regenerative medicine to offer treatments and cures for patients suffering from a broad array of illnesses including degenerative muscle diseases, osteoporosis and diabetes. The goal of this project is to test a hypothesis of how stem cell fate decisions are regulated in vivo. Elucidating the answer to this critical question in biology would facilitate the translation of the science of stem cell biology to the bedside for the development of novel therapies.
描述(由申请人提供)
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
Adipose circadian clocks: coordination of metabolic rhythms by clock genes, steroid hormones, and PPARs.
脂肪生物钟:通过时钟基因、类固醇激素和 PPAR 协调代谢节律。
- DOI:10.1515/hmbci-2013-0011
- 发表时间:2013
- 期刊:
- 影响因子:1
- 作者:Krueger,KatherineC;Feldman,BrianJ
- 通讯作者:Feldman,BrianJ
The development of next-generation screening and diagnostic platforms will change diabetes care.
下一代筛查和诊断平台的开发将改变糖尿病护理。
- DOI:10.1586/14737159.2015.1002468
- 发表时间:2015
- 期刊:
- 影响因子:5.1
- 作者:Kumar,RajivB;Gupta,Mihir;Feldman,BrianJ
- 通讯作者:Feldman,BrianJ
Characterization of Cre recombinase activity for in vivo targeting of adipocyte precursor cells.
CRE重组酶活性的表征是脂肪细胞前体细胞的体内靶向。
- DOI:10.1016/j.stemcr.2014.10.009
- 发表时间:2014-12-09
- 期刊:
- 影响因子:5.9
- 作者:Krueger, Katherine C.;Costa, Maria Jose;Du, Hongqing;Feldman, Brian J.
- 通讯作者:Feldman, Brian J.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brian J Feldman其他文献
Brian J Feldman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brian J Feldman', 18)}}的其他基金
Molecular responses and physiological implications to systemic stimuli in adipocyte progenitor cells
脂肪祖细胞对全身刺激的分子反应和生理学意义
- 批准号:
10420760 - 财政年份:2022
- 资助金额:
$ 239.22万 - 项目类别:
Molecular responses and physiological implications to systemic stimuli in adipocyte progenitor cells
脂肪祖细胞对全身刺激的分子反应和生理学意义
- 批准号:
10615751 - 财政年份:2022
- 资助金额:
$ 239.22万 - 项目类别:
Integrated Systemic and Adipose Depot-Specific Regulation of Adipogenesis
脂肪生成的综合系统和脂肪库特异性调节
- 批准号:
10163160 - 财政年份:2019
- 资助金额:
$ 239.22万 - 项目类别:
The Role of Glucocorticoids in Cell Fate Determination
糖皮质激素在细胞命运决定中的作用
- 批准号:
7643239 - 财政年份:2006
- 资助金额:
$ 239.22万 - 项目类别:
The Role of Glucocorticoids in Cell Fate Determination
糖皮质激素在细胞命运决定中的作用
- 批准号:
7252424 - 财政年份:2006
- 资助金额:
$ 239.22万 - 项目类别:
The Role of Glucocorticoids in Cell Fate Determination
糖皮质激素在细胞命运决定中的作用
- 批准号:
7429813 - 财政年份:2006
- 资助金额:
$ 239.22万 - 项目类别:
The Role of Glucocorticoids in Cell Fate Determination
糖皮质激素在细胞命运决定中的作用
- 批准号:
7141363 - 财政年份:2006
- 资助金额:
$ 239.22万 - 项目类别:
The Role of Glucocorticoids in Cell Fate Determination
糖皮质激素在细胞命运决定中的作用
- 批准号:
7892581 - 财政年份:2006
- 资助金额:
$ 239.22万 - 项目类别:
相似国自然基金
Journal of Integrative Plant Biology
- 批准号:31024801
- 批准年份:2010
- 资助金额:24.0 万元
- 项目类别:专项基金项目
相似海外基金
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 239.22万 - 项目类别:
Operating Grants
Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Lung Diseases
肺生物学和肺部疾病中的干细胞、细胞疗法和生物工程
- 批准号:
10753310 - 财政年份:2023
- 资助金额:
$ 239.22万 - 项目类别:
Decoding and reprogramming T cells through synthetic biology for cancer immunotherapy
通过合成生物学解码和重编程 T 细胞用于癌症免疫治疗
- 批准号:
10568704 - 财政年份:2023
- 资助金额:
$ 239.22万 - 项目类别:
Quantitative systems biology of glioblastoma cells and their interactions with the neuronal and immunological milieu
胶质母细胞瘤细胞的定量系统生物学及其与神经元和免疫环境的相互作用
- 批准号:
10729273 - 财政年份:2023
- 资助金额:
$ 239.22万 - 项目类别:
Conference: Stem Cells, Cell Therapy and Bioengineering in Lung Biology and Diseases 2023
会议:肺生物学和疾病中的干细胞、细胞治疗和生物工程 2023
- 批准号:
2327935 - 财政年份:2023
- 资助金额:
$ 239.22万 - 项目类别:
Standard Grant
Development of Innovative Fat Transplantation Based on Single Cell Analysis and Computational Biology of Subcutaneous Adipose Tissue-Derived Cells
基于皮下脂肪组织来源细胞的单细胞分析和计算生物学的创新脂肪移植的发展
- 批准号:
22H03246 - 财政年份:2022
- 资助金额:
$ 239.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A Long Path to Power: combining bioengineering, stem cells and cell biology to uncover the mysteries of axonal biology
权力之路漫漫:结合生物工程、干细胞和细胞生物学,揭开轴突生物学的奥秘
- 批准号:
2723028 - 财政年份:2022
- 资助金额:
$ 239.22万 - 项目类别:
Studentship
Expanding retinal regenerative potential through chromatin biology in single cells
通过单细胞染色质生物学扩大视网膜再生潜力
- 批准号:
10463028 - 财政年份:2022
- 资助金额:
$ 239.22万 - 项目类别:
Biology of Submucosal Gland Stem Cells in the Airway
气道粘膜下腺干细胞的生物学
- 批准号:
10516449 - 财政年份:2022
- 资助金额:
$ 239.22万 - 项目类别:
Society for Basic Urology Research 2022 Fall Meeting: Complex Cells, Systems and Regulatory Pathways In Urologic Biology
基础泌尿学研究学会 2022 年秋季会议:泌尿生物学中的复杂细胞、系统和调节途径
- 批准号:
10609175 - 财政年份:2022
- 资助金额:
$ 239.22万 - 项目类别:














{{item.name}}会员




